GTBP icon

GT Biopharma
GTBP

16 hedge funds and large institutions have $35.3M invested in GT Biopharma in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$5.36M
2
+$8.84K

Top Sellers

1
-$20.3K
2
-$11.7K
3
-$1.22K
4
BlackRock
BlackRock
New York
-$72
5
FRA
Front Row Advisors
California
-$3
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$35.1M
2
$63K
3
$34.5K
4
$24.1K
5
$23.1K
6
$23.1K
7
$22.5K
8
$9.01K
9
$3.79K
10
$614
11
$62
12
$28
13
$23
14
$14
15
$2
16
–